Table 1.
Summary of the 10 most up- and down-regulated transcripts and their fold-change relative to the median value of the normal samples
| Gene symbol | Gene name | Log2 ratio (fold change up-regulated) | Gene symbol | Gene name | Log2 ratio (fold change down-regulated) |
|---|---|---|---|---|---|
| DEFA6 | Defensin | 5.13 (35x) | DARC | Blood group-Duffy system | -4.03 (16x) |
| CDH3 | P-cadherin | 4.84 (29x) | C3 | Complement component 3 | -4.11 (17x) |
| KIAA1199 | Inner ear protein | 4.57 (24x) | CR2 | Complement component receptor 2 | -4.12 (17x) |
| MSX2 | Muscle segment homeobox 2 | 4.45 (22x) | MYL9 | Myosin light chain 9 | -4.30 (20x) |
| SLCO1B3 | 4.21 (19x) | IGLV3-10 | -4.32 (20x) | ||
| PCSK1 | Proprotein convertase 1 | 3.96 (16x) | CXCL13 | Chemokine ligand 13 | -4.34 (20x) |
| TACSTD2 | Tumour-associated Ca signal transducer 2 | 3.84 (14x) | CCL21 | Chemokine ligand 21 | -4.43 (22x) |
| LCN2 | Lipocalin 2 | 3.59 (12x) | PYY | Peptide YY | -4.62 (24x) |
| XIST | X inactivation-specific transcript | 3.58 (12x) | FBLN1 | Fibulin 1 | -4.63 (25x) |
| FZD3 | Frizzled homolog 3 | 3.55 (12x) | CCL19 | Chemokine ligand 19 | -5.33 (40x) |